Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma
Blakaj A, Stein SM, Khan SA, Johung KL. Review and current state of radiation therapy for locally advanced pancreatic adenocarcinoma. Journal Of Gastrointestinal Oncology 2018, 9: 1027-1036. PMID: 30603121, PMCID: PMC6286948, DOI: 10.21037/jgo.2018.03.07.Peer-Reviewed Original ResearchStereotactic body radiation therapyManagement of LAPCRadiation therapyPancreatic cancerGood treatment tolerabilityProgressive local diseaseAdvanced pancreatic adenocarcinomaAdvanced pancreatic cancerEffective systemic therapyOverall poor prognosisBody radiation therapyTime of deathAreas of controversyTreatment tolerabilityLocal progressionSystemic regimensSurvival benefitSystemic therapyDose escalationImmune therapySignificant morbidityLocal diseasePoor prognosisOptimal treatmentPancreatic adenocarcinomaClinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma
Zhu R, Liu F, Grisotti G, Perez-Irizarry J, Salem RR, Cha CH, Johung KL, Boffa DJ, Zhang Y, Khan SA. Clinical impact of underutilization of adjuvant therapy in node positive gastric adenocarcinoma. Journal Of Gastrointestinal Oncology 2018, 9: 517-526. PMID: 29998017, PMCID: PMC6006033, DOI: 10.21037/jgo.2018.03.05.Peer-Reviewed Original ResearchPost-operative chemoradiationPeri-operative chemotherapyNode-positive gastric cancerAdjuvant therapyPositive gastric cancerGastric adenocarcinomaAdjuvant chemotherapyGastric cancerCurative-intent gastrectomyNational Cancer DatabasePercentage of patientsThird of patientsMean survival timeMultimodality careCurative gastrectomyOverall survivalSurgical resectionCancer outcomesCancer DatabasePoor survivalClinical impactLong-term effectsRadiation therapySurvival advantageSurvival time